| BYND 1.18 1.72% | LOBO 0.7316 27.77% | ASBP 0.2361 -9.85% | CTNT 0.0442 -19.34% | FCHL 0.2595 15.33% | XRTX 2.84 26.22% | LOCL 2.7298 45.20% | EDBL 1.0245 11.36% | SOWG 0.156 -34.97% | TOVX 0.312 -23.90% | NVTS 16.17 22.50% | POET 10.41 21.19% | RPGL 0.7451 65.61% | SOXS 18.0295 -3.22% | HIMS 30.46 -1.77% | CLIK 3.6999 43.96% | INTC 66.94 1.89% | NVDA 201.5101 -0.27% | TSLL 13.17 -0.90% | PLUG 3.2 -0.62% | TQQQ 58.529 0.77% | BURU 0.2399 19.95% | BIYA 1.1926 37.06% | TZA 4.8901 -2.10% | SOUN 8.435 1.38% | LCID 7.625 12.96% | SLNH 1.4498 3.56% | OPEN 5.755 7.57% | BULL 7.205 2.78% | SOXL 99.08 3.27% | ONDS 11.1115 3.56% | LZMH 0.1181 -23.81% | NOK 10.585 -0.14% | SMR 12.53 -2.03% | SNAP 5.765 -3.92% | BITO 10.4399 -0.19% | SOFI 19.53 0.15% | SQQQ 56.48 -0.76% | PLTR 148.31 1.66% | SPRC 5.6701 34.04% | DVLT 0.7655 3.80% | NFLX 93.6601 -1.23% | FFAI 0.3297 15.00% | TSLA 390.81 -0.43% | AMZN 252.5026 1.70% | ALBT 0.3966 -19.03% | GPUS 0.1594 6.13% | HTZ 7.73 -1.02% | MRVL 153.17 3.61% | GNPX 1.1999 3.89%

Freshpet Surges 6% On Strong Earnings Despite Lower Sales Outlook

Freshpet (NASDAQ:FRPT) posted second-quarter results that exceeded earnings expectations, lifting shares over 6% today, despite missing revenue forecasts and trimming its sales guidance.

The company reported adjusted earnings per share of $0.33, well ahead of the $0.11 consensus. Revenue rose 12.5% year-over-year to $264.7 million, falling short of the $267.85 million forecast. Growth was driven by a 10.8% increase in volume and a 1.7% favorable price/mix.

Freshpet posted net income of $16.4 million versus a loss of $1.7 million a year ago. Gross margin improved to 40.9%, up from 39.9%, while adjusted EBITDA rose to $44.4 million from $35.1 million in the same period last year.

Freshpet lowered its 2025 net sales growth forecast to 13–16%, down from 15–18%, citing consumer economic pressures. However, it maintained its adjusted EBITDA target of $190–$210 million and reduced its capital spending outlook to $175 million from $225 million.

The company also withdrew its long-term $1.8 billion sales target for 2027 but reaffirmed its adjusted gross margin goal of 48% and EBITDA margin target of 22%.

Published on: August 4, 2025